Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Gawlik

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Molecular Medicine|August 17, 2005
Conditional gene targeting in the kidneyAlexander Gawlik, Susan E Quaggin
Physiology (Bethesda, Md.)|September 24, 2004
Deciphering the renal code: advances in conditional gene targetingAlexander Gawlik, Susan E Quaggin
The Journal of Clinical Investigation|May 25, 2011
Angiopoietin-1 is essential in mouse vasculature during development and in response to injuryMarie Jeansson, Alexander Gawlik, Gregory Anderson, et al.
Kidney International|February 19, 2002
Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritisRalf Westenfeld, Alexander Gawlik, Emile de Heer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2011
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone diseaseRalf Westenfeld, Georg Schlieper, Michael Wöltje, et al.
Kidney International|February 19, 2002
Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritisMarkus Ketteler, Ralf Westenfeld, Alexander Gawlik, et al.
Journal of the American Society of Nephrology : JASN|September 2, 2004
Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptorsTammo Ostendorf, Claudia Van Roeyen, Ralf Westenfeld, et al.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Molecular Medicine|August 17, 2005
Conditional gene targeting in the kidneyAlexander Gawlik, Susan E Quaggin
Physiology (Bethesda, Md.)|September 24, 2004
Deciphering the renal code: advances in conditional gene targetingAlexander Gawlik, Susan E Quaggin
The Journal of Clinical Investigation|May 25, 2011
Angiopoietin-1 is essential in mouse vasculature during development and in response to injuryMarie Jeansson, Alexander Gawlik, Gregory Anderson, et al.
Kidney International|February 19, 2002
Selective inhibition of inducible nitric oxide synthase enhances intraglomerular coagulation in chronic anti-Thy 1 nephritisRalf Westenfeld, Alexander Gawlik, Emile de Heer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 31, 2011
Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone diseaseRalf Westenfeld, Georg Schlieper, Michael Wöltje, et al.
Kidney International|February 19, 2002
Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritisMarkus Ketteler, Ralf Westenfeld, Alexander Gawlik, et al.
Journal of the American Society of Nephrology : JASN|September 2, 2004
Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptorsTammo Ostendorf, Claudia Van Roeyen, Ralf Westenfeld, et al.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Pageof 1